Jacobs Flavia, D'Amico Saverio, Zazzetti Elena, Gaudio Mariangela, Benvenuti Chiara, Saltalamacchia Giuseppe, Gerosa Riccardo, Gentile Damiano, Lasagna Angioletta, Pedrazzoli Paolo, Tinterri Corrado, Santoro Armando, De Sanctis Rita, Porta Matteo Della, Zambelli Alberto
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Humanitas Clinical and Research Center-IRCCS, Humanitas Cancer Center, Milan, Italy.
Digit Health. 2024 Nov 3;10:20552076241288821. doi: 10.1177/20552076241288821. eCollection 2024 Jan-Dec.
Modern healthcare is experiencing a significant transformation, utilizing technology to improve patient outcomes and make processes more efficient. Breast cancer, being the most commonly diagnosed cancer in women globally, requires innovative approaches for effective management. Digital Therapeutics (DTx) and Clinical Decision Support Systems (CDSSs) have emerged as pivotal technologies, offering personalized, patient-centered care and optimizing clinical decision-making. This review provides a comprehensive analysis of the applications, benefits, and challenges of these digital tools in breast cancer treatment. We examine DTx tools' ability to offer real-time symptom monitoring, treatment adherence, psychological support, and lifestyle modification guidance. Simultaneously, the role of CDSSs in providing personalized treatment recommendations, early detection, data analysis, and enhancing multidisciplinary collaborations is evaluated. The challenges of implementing these technologies, such as data privacy, interoperability, and accessibility are also discussed, along with potential solutions. By exploring the current research findings, the review underscores the significant impact of DTx and CDSSs on patient outcomes, treatment efficiency, and overall quality of life. This manuscript concludes with a forward-looking perspective, emphasizing the importance of collaborative efforts to overcome obstacles and unlock the full potential of digital innovations in breast cancer oncology. Our analysis suggests that adopting these digital tools can lead to more holistic, efficient, and patient-centric cancer care, marking a significant shift in the paradigm of breast cancer management.
现代医疗保健正在经历重大变革，利用技术改善患者治疗效果并提高流程效率。乳腺癌是全球女性中最常被诊断出的癌症，需要创新方法进行有效管理。数字疗法（DTx）和临床决策支持系统（CDSS）已成为关键技术，提供个性化、以患者为中心的护理并优化临床决策。本综述对这些数字工具在乳腺癌治疗中的应用、益处和挑战进行了全面分析。我们研究了DTx工具提供实时症状监测、治疗依从性、心理支持和生活方式改变指导的能力。同时，评估了CDSS在提供个性化治疗建议、早期检测、数据分析以及加强多学科协作方面的作用。还讨论了实施这些技术的挑战，如数据隐私、互操作性和可及性，以及潜在的解决方案。通过探索当前的研究结果，本综述强调了DTx和CDSS对患者治疗效果、治疗效率和总体生活质量的重大影响。本文最后以前瞻性的视角强调了合作努力克服障碍并释放数字创新在乳腺癌肿瘤学中全部潜力的重要性。我们的分析表明，采用这些数字工具可以带来更全面、高效且以患者为中心的癌症护理，标志着乳腺癌管理模式的重大转变。
